Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,747 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antifibrotic effect and long-term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus.
Arai T, Atsukawa M, Tsubota A, Mikami S, Haruki U, Yoshikata K, Ono H, Kawano T, Yoshida Y, Tanabe T, Okubo T, Hayama K, Nakagawa-Iwashita A, Itokawa N, Kondo C, Kaneko K, Nagao M, Inagaki K, Fukuda I, Sugihara H, Iwakiri K. Arai T, et al. Among authors: kawano t. Hepatol Commun. 2022 Nov;6(11):3073-3082. doi: 10.1002/hep4.2069. Epub 2022 Aug 30. Hepatol Commun. 2022. PMID: 36039537 Free PMC article.
Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease.
Arai T, Atsukawa M, Tsubota A, Kawano T, Koeda M, Yoshida Y, Tanabe T, Okubo T, Hayama K, Iwashita A, Itokawa N, Kondo C, Kaneko K, Kawamoto C, Hatori T, Emoto N, Iio E, Tanaka Y, Iwakiri K. Arai T, et al. Among authors: kawano t. PLoS One. 2019 Nov 13;14(11):e0224184. doi: 10.1371/journal.pone.0224184. eCollection 2019. PLoS One. 2019. PMID: 31721770 Free PMC article.
Prevalence and characteristics of portopulmonary hypertension in cirrhotic patients who underwent both hepatic vein and pulmonary artery catheterization.
Atsukawa M, Tsubota A, Hatano M, Kondo C, Shioda K, Ohno H, Kawano T, Hayama K, Arai T, Nakagawa-Iwashita A, Itokawa N, Kaneko K, Yoshida Y, Koeda M, Okubo T, Yamamoto T, Yamamoto T, Taniai N, Yoshida H, Kanazawa H, Shimizu W, Iwakiri K. Atsukawa M, et al. Among authors: kawano t. Hepatol Res. 2020 Nov;50(11):1244-1254. doi: 10.1111/hepr.13560. Epub 2020 Sep 1. Hepatol Res. 2020. PMID: 32822521
Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data.
Arai T, Atsukawa M, Tsubota A, Mikami S, Ono H, Kawano T, Yoshida Y, Tanabe T, Okubo T, Hayama K, Nakagawa-Iwashita A, Itokawa N, Kondo C, Kaneko K, Emoto N, Nagao M, Inagaki K, Fukuda I, Sugihara H, Iwakiri K. Arai T, et al. Among authors: kawano t. Ther Adv Endocrinol Metab. 2021 Mar 21;12:20420188211000243. doi: 10.1177/20420188211000243. eCollection 2021. Ther Adv Endocrinol Metab. 2021. PMID: 33815743 Free PMC article.
Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A Prospective, Randomized, Controlled Pilot Trial.
Okubo T, Atsukawa M, Tsubota A, Ono H, Kawano T, Yoshida Y, Arai T, Hayama K, Itokawa N, Kondo C, Kaneko K, Iwakiri K. Okubo T, et al. Among authors: kawano t. Nutrients. 2021 May 30;13(6):1874. doi: 10.3390/nu13061874. Nutrients. 2021. PMID: 34070910 Free PMC article. Clinical Trial.
Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease.
Arai T, Atsukawa M, Tsubota A, Kato K, Abe H, Ono H, Kawano T, Yoshida Y, Tanabe T, Okubo T, Hayama K, Nakagawa-Iwashita A, Itokawa N, Kondo C, Kaneko K, Emoto N, Nagao M, Inagaki K, Fukuda I, Sugihara H, Iwakiri K. Arai T, et al. Among authors: kawano t. Sci Rep. 2021 Aug 5;11(1):15938. doi: 10.1038/s41598-021-95581-8. Sci Rep. 2021. PMID: 34354193 Free PMC article.
Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease.
Kawano T, Atsukawa M, Tsubota A, Shimada N, Toyoda H, Takaguchi K, Tani J, Morishita A, Hiraoka A, Mikami S, Ishikawa T, Okubo H, Watanabe T, Okubo T, Arai T, Hayama K, Itokawa N, Kondo C, Iwakiri K. Kawano T, et al. Sci Rep. 2022 May 4;12(1):7311. doi: 10.1038/s41598-022-11431-1. Sci Rep. 2022. PMID: 35508514 Free PMC article.
Efficacy and safety of oral semaglutide in patients with non-alcoholic fatty liver disease complicated by type 2 diabetes mellitus: A pilot study.
Arai T, Atsukawa M, Tsubota A, Ono H, Kawano T, Yoshida Y, Okubo T, Hayama K, Nakagawa-Iwashita A, Itokawa N, Kondo C, Nagao M, Iwakiri K. Arai T, et al. Among authors: kawano t. JGH Open. 2022 Jun 16;6(7):503-511. doi: 10.1002/jgh3.12780. eCollection 2022 Jul. JGH Open. 2022. PMID: 35822119 Free PMC article.
Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study.
Atsukawa M, Tsubota A, Kondo C, Koyano KS, Ishikawa T, Toyoda H, Takaguchi K, Watanabe T, Matsuura K, Ogawa C, Hiraoka A, Okubo H, Tateyama M, Uojima H, Nozaki A, Chuma M, Kato K, Mikami S, Tani J, Morishita A, Kawata K, Tada T, Furuichi Y, Okubo T, Kawano T, Arai T, Kawabe N, Kawamura N, Ikegami T, Nakamuta M, Shigefuku R, Iwasa M, Tanaka Y, Hatano M, Iwakiri K. Atsukawa M, et al. Among authors: kawano t. Hepatol Int. 2023 Feb;17(1):139-149. doi: 10.1007/s12072-022-10456-y. Epub 2022 Dec 7. Hepatol Int. 2023. PMID: 36477691 Clinical Trial.
1,747 results